Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

New PPAR modulators discovered by Novo Nordisk researchers

May 19, 2003

Schering AG presents new estrogenic agents for contraception and cancer therapy

May 19, 2003

ISIS-113715 evaluated in new phase I trial for type 2 diabetes

May 16, 2003

Botanical product for hypertriglyceridemia unveiled at recent meeting

May 15, 2003

New antiobesity MCHR1 antagonists in GSK pipeline

May 15, 2003

Novel glucose-lowering 11CBy antagonists identified at GSK

May 15, 2003

Novel aldose reductase inhibitors covered by Otsuka patent

May 14, 2003

Melanocortin receptor modulators in early development at Neurocrine Biosciences

May 14, 2003

Neurochem licenses preclinical diabetes technology to Innodia

May 14, 2003

BioSante announces positive phase II/III results for Bio-E-Gel

May 14, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 26, 2026.
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
Case report links APOLD1 variant to vascular-type bleeding disorder
BioWorld Science
Vascular-type bleeding disorder (BDVAS) is a rare, autosomal dominant disorder mainly caused by impaired vascular integrity.
2026 marks critical turning point for BCI technology
BioWorld
Decades of research are helping unravel the “black box” of the brain. The second article in BioWorld’s series on the Brain-Computer Interface (BCI) field looks at...
Next wave of BCI firms builds on pioneers to tackle challenges
BioWorld
With the pace of neurotechnology development accelerating, a wave of brain-computer interface (BCI) companies is emerging on the heels of the pioneers. In the...